Seneca House Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$224K Buy
1,740
+76
+5% +$8.9K 0.08% 95
2026
Q1
$200K Sell
1,664
-457
-22% -$52.8K 0.08% 96
2025
Q4
$223K Buy
+2,121
New +$199K 0.08% 95
2025
Q1
Sell
-2,162
Closed -$215K 88
2024
Q4
$215K Buy
2,162
+86
+4% +$8.87K 0.09% 86
2024
Q3
$236K Buy
2,076
+63
+3% +$7.49K 0.1% 79
2024
Q2
$249K Buy
2,013
+53
+3% +$6.83K 0.11% 74
2024
Q1
$259K Buy
1,960
+2
+0.1% +$247 0.11% 74
2023
Q4
$214K Sell
1,958
-60
-3% -$6.23K 0.1% 73
2023
Q3
$211K Sell
2,018
-104
-5% -$11.2K 0.11% 73
2023
Q2
$245K Buy
2,122
+1
+0% +$114 0.12% 76
2023
Q1
$226K Buy
2,121
+150
+8% +$16.2K 0.12% 80
2022
Q4
$219K Buy
+1,971
New +$201K 0.12% 81
2021
Q4
Sell
-3,099
Closed -$233K 92
2021
Q3
$233K Buy
3,099
+160
+5% +$12.2K 0.14% 81
2021
Q2
$229K Buy
+2,939
New +$219K 0.15% 78

Other funds holding MRK

Seneca House Advisors's MRK Position: Q2 2026 in Review

Seneca House Advisors increased its Merck (MRK) stake by 4.6% in Q2 2026, buying an estimated $8.9K and bringing the position to 1,740 shares worth $224K. The position accounts for 0.08% of the portfolio, ranked #95.

Seneca House Advisors first reported a position in MRK in Q2 2021 and has held it in 14 quarters since. The position peaked at $259K in Q1 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Seneca House Advisors held 1,740 shares of Merck worth $224K as of Q2 2026.
  • Seneca House Advisors bought 76 Merck shares in Q2 2026, an estimated $8.9K.
  • Merck made up 0.08% of Seneca House Advisors's portfolio in Q2 2026, its #95 holding.
  • Seneca House Advisors first reported a position in Merck in Q2 2021 and has held it in 14 quarters since.
  • Seneca House Advisors's Merck position peaked at $259K in Q1 2024.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Seneca House Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.